Beruflich Dokumente
Kultur Dokumente
HYPERTENSION IN PREGNANCY
Historically, hypertension and pregnancy have intertwined, sometimes causing maternal death. At the turn of the 20th century, one in 100 live births resulted in maternal death, according to WHO.
Chronic HTN
Chronic Hypertension
Pre-existing Hypertension Systolic pressure 140 mmHg, diastolic pressure 90 mmHg, or both. Presents before 20th week of pregnancy or persists longer than 12th weeks postpartum. Chronic hypertension is caused by Primary = Essential Hypertension Secondary HTN = Result of other medical conditions
Continue..
Conclusion: Pregnant women with chronic hypertension have significantly increased risks of maternal and perinatal morbidity and mortality.
Gestational Hypertension
Mild hypertension without proteinuria or other signs of preeclampsia. Develops in late pregnancy, after 20th weeks gestation.
One fourth of women with gestational hypertension develop proteinuria and thus progress to pre-eclampsia.
Pre-eclampsia
New onset of hypertension and proteinuria after 20th weeks gestation. Systolic blood pressure 140 mmHg OR diastolic blood pressure 90 mmHg Proteinuria of 0.3 g or greater in a 24-hour urine
Incidence: In India, pre-eclampsia occurs in 10% primigravidae (women pregnant for 1st time) and 5% in multigravidae (a woman who is pregnant and has been pregnant at least twice before) in hospital.
Dutta DC. Textbook of obstetrics. 5th edition. Central publication, 234-255
Continue..
Continue..
Continue..
Continue..
Eclampsia, a severe complication of pre-eclampsia, is the new onset of seizures in a woman with pre-eclampsia. Eclampsia seizures are relatively rare and occur in <1% of women with pre-eclampsia.
Up to 40% of eclamptic seizures occur before delivery; approximately 16% occur more than 48hrs after delivery
Pregnancy associated factors Chromosomal abnormalities Hydatidiform mole Hydrops fetalis Multifetal pregnancy Urinary tract infections New paternity First time father Previously fathered a pre-eclamptic pregnancy in another woman
Maternal-specific factors Age <20years & >35 years Family history of pre-eclampsia Nulliparity
with
the
following
additional
Hypertension and proteinuria beginning prior to 20th weeks of gestation. A sudden increase in blood pressure. Development of the HELLP (Hemolysis, Elevated liver enzymes, Low platelet count) syndrome.
Gestational HTN
Systolic pressure 140 mmHg & diastolic pressure 90 mmHg, or both
Pre-eclampsia
Eclampsia
Severe grade of preeclampsia leads to seizures & dangerous to fetus & mother
BP + Proteinuria + Edema
Differentiation Algorithm
Etiology
American Journal of Obstetrics & Gynecology .1999 Jan;180(1 Pt 1):207-13 Indian J Pediatr 2007; 74 (7) : 623-625
Management
Rest: Continued till all the pre-eclampsia manifestations subside.
Antihypertensive: The common oral drugs used are either Labetalol or Methyldopa.
Labetalol is a popular first-line antihypertensive of choice in the treatment of hypertension. Most preferred antihypertensive drug among UK consultants in the management of severe pre-eclampsia and eclampsia. Useful in PIH because reduced placental transfer occurs, mainly due to low lipid solubility.
Obstetrics, Gynaecology & Reproductive Medicine.2009;19(5):136-141; Br J Obstet Gynaecol. 1992; 99:554-556 Ultrasound in Medicine and Biology.2011; 37 (1): 53-58
Pharmacokinetics
Labetalol is completely absorbed.
Peak plasma concentrations is achieved within 2 hours. Relative bioavailability of oral labetalol is 100%. About 50% of the drug is bound in the plasma. Half-life of labetalol is 6 to 8 hours. Metabolized in liver and excreated through urine and bile.
Prac Diab Int.2011:28(3): 139-140 Lippincott . 5th edition.
Significant reduction in maternal mean arterial pressure (MAP) was found with labetalol which was sustained over a 5 weeks period (P<0.01).
British Journal of Obstetrics and Gynaecology.1989 Jan; 96(1):38-43
Continue..
Some reduction in preterm delivery, neonatal respiratory distress syndrome and jaundice was observed in the labetalol treated group.
Conclusion: Labetalol appeared to be an effective and safe agent in the management of mild to moderate pregnancy-induced hypertension.
N =104 primigravidas (a woman pregnant for the first time) with mild to moderate PIH
Group A: Labetalol (100 mg t.i.d.) n=54 Group B: Methyldopa (250 mg t.i.d.) ...n=50
Dose of both the drugs were doubled every 48 hrs to maintain MAP103.6 mmHg upto maximum dose of 900 mg labetalol and 2250 mg methyldopa per day.
International Journal of Gynecology & Obstetrics.1995 May;49(2):125-30
Continue..
Continue..
Continue..
Oral Labetalol Methyldopa No abnormality was No abnormality was observed observed Beneficial effect on renal function by No beneficial effect was observed reducing incidence of proteinurea 48% 63%
Rate of induction of labor for uncontrolled PIH Rate of cesarean section for uncontrolled PIH
1%
5.6%
Continue..
Continue..
50 infants (100%) in labetalol group and 46 (85.2%) in methyldopa group were reviewed at 18 months of age. All had been developing normally, both physically and mentally.
Conclusion: Labetalol was better tolerated than methyldopa, gives more efficient control of blood pressure and may have a ripening effect on the uterine cervix.
International Journal of Gynecology & Obstetrics.1995 May;49(2):125-30
Continue..
In another comparative study between Labetalol and Methyldopa, a more satisfactory control of blood pressure was obtained with labetalol with minimal side-effects.
After 2 weeks labetalol treatment renal function had significantly improved with a markedly lower incidence of proteinuria.
No adverse effects attributable to labetalol were noted in the baby either ante- or post-natally.
Continue..
Blood pressure control was more frequently achieved in hypertensive pregnancies with labetalol than with methyldopa as a first line treatment.
Labetalol was safe to the fetus and newborn and might offer a better prevention of intrauterine
Safety
Labetalol was generally well tolerated but may cause fatigue, headache, postural hypotension, nasal stiffness, and gastrointestinal symptoms (if it is used in high doses).
Labetalol treatment was not related to any significant changes in fetal doppler.
No perinatal deaths were reported with labetalol treatment. Labetalol allows safe complicated by PIH. prolongation of pregnancies
International Journal of Gynecology & Obstetrics.1995 May;49(2):125-30; Dollery C. Therapeutic drugs.2nd edition: L1-L7 Ultrasound in Medicine and Biology.2011; 37 (1): 53-58
National Institute for Health and Clinical Excellence (NICE) guidance on the management of hypertensive disorders during pregnancy recommends oral labetalol as first line treatment to keep diastolic BP between 80100 mmHg and systolic BP <150 mmHg in the management of gestational hypertension and pre-eclampsia.
American college of obstetricians & Gynecologists (ACOG) and Royal college of obstetricians & Gynecologists (RCOG) also recommends labetalol as a first line treatment in the treatment of Pre-eclampsia.
Diuretics
Atenolol
to
Adv Chronic Kidney Dis. 2007;14(2):178-90; Semin Nephrol. 2011;31(1):70-85; Am J Psychiatry. 2003 ;160(3):464-8; CMA.1978;118:936; Rev Med Suisse. 2007 Sep 12;3(124):2012
Methyldopa
Drowsiness, Nasal Congestion, Headache, Postural hypotension & Intrauterine death are reported.
Nicardipine
Tachycardia is reported.
Hydralazine
Am J Obstet Gynecol. 2002 Oct;187(4):1046-50.; Intensive Care Med. 2002 Sep;28(9):1281-6; Am J Health Syst Pharm. 2009 Feb 15;66(4):337-44.
Contraindications
Labetalol is contraindicated in women with a history of asthma. Labetalol should be used with caution in cardiac disease.
Dosage
Labetalol 100 mg twice or thrice in a day. If blood pressure control is unsatisfactory then dose can be doubled every 48 hrs up to maximum 900 mg per day.
OR
As directed by physician
of
gestational
It is quicker and more efficient at controlling blood pressure. Better tolerated than Methyldopa. Improves renal function by reducing incidence of proteinurea. May help to ripen uterine cervix thus increase the rate of vaginal delivery.